Articles with "preclinical testing" as a keyword



Photo by thinkmagically from unsplash

In vivo kinematical validated knee model for preclinical testing of total knee replacement

Sign Up to like & get
recommendations!
Published in 2021 at "Computers in biology and medicine"

DOI: 10.1016/j.compbiomed.2021.104311

Abstract: BACKGROUND AND OBJECTIVE A computational knee model facilitates efficient component design evaluations and preclinical testing under various dynamic loadings. However, the development of a highly mimicked dynamic whole knee model with specified ligament constraints that… read more here.

Keywords: preclinical testing; model; translation rmse; knee model ... See more keywords
Photo from wikipedia

Maximizing the potential of aggressive mouse tumor models in preclinical drug testing

Sign Up to like & get
recommendations!
Published in 2021 at "Scientific Reports"

DOI: 10.1038/s41598-021-91167-6

Abstract: Atypical teratoid rhabdoid tumor (ATRT) is an aggressive embryonal brain tumor among infants and young children. Two challenges exist for preclinical testing in ATRT. First, genetically quiet, ATRT is a difficult tumor to target molecularly.… read more here.

Keywords: drug testing; preclinical testing; preclinical drug; drug ... See more keywords
Photo by tcooper86 from unsplash

Abstract 2275: Preclinical testing of therapeutic biologics using patient-derived 3D spheroids

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-2275

Abstract: Biological therapies for the treatment of cancer are utilized for the same ultimate purpose as chemically derived cancer drugs, to induce tumor cell death. However, the differing mechanisms of action often make the evaluation of… read more here.

Keywords: cell; efficacy; patient derived; tumor ... See more keywords
Photo from wikipedia

A Single Mouse Trial Platform for Evaluation of Novel Agents in Acute Lymphoblastic Leukemia By the Pediatric Preclinical Testing Consortium

Sign Up to like & get
recommendations!
Published in 2018 at "Blood"

DOI: 10.1182/blood-2018-99-113207

Abstract: Introduction: While children diagnosed with the most common pediatric malignancy, acute lymphoblastic leukemia (ALL), now experience close to a 90% likelihood of cure, the outcome for several high-risk subtypes remains poor. Furthermore, since standard-of-care drugs… read more here.

Keywords: trial; response; preclinical testing; single mouse ... See more keywords
Photo by mykjohnson from unsplash

Evaluation of the TPO-receptor agonist Eltrombopag in the Pediatric Preclinical Testing Consortium osteosarcoma in vivo models.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2019.37.15_suppl.e22502

Abstract: e22502 Background: Eltrombopag (EP) is a small molecule, thrombopoietin receptor (TPO-R) agonist indicated for the treatment of patients with chronic immune thrombocytopenia and severe aplastic anemia. EP is a polyvalent cation chelator and inhibits leukemia… read more here.

Keywords: preclinical testing; osteosarcoma; pdx models; receptor ... See more keywords
Photo from wikipedia

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma

Sign Up to like & get
recommendations!
Published in 2017 at "Oncotarget"

DOI: 10.18632/oncotarget.18520

Abstract: Rhabdomyosarcoma (RMS) is the most common childhood soft tissue sarcoma. RMS often arise from myogenic precursors and displays a poorly differentiated skeletal muscle phenotype most closely resembling regenerating muscle. GSK3β is a ubiquitously expressed serine-threonine… read more here.

Keywords: preclinical testing; kinase; rhabdomyosarcoma; inhibitor tideglusib ... See more keywords
Photo from wikipedia

Characteristics of Extracellular Vesicles and Preclinical Testing Considerations Prior to Clinical Applications

Sign Up to like & get
recommendations!
Published in 2022 at "Biomedicines"

DOI: 10.3390/biomedicines10040869

Abstract: Cell therapy products have significant limitations, such as storage instability, difficulties with transportation, and toxicity issues such as tumorigenicity and immunogenicity. Extracellular vesicles (EVs) secreted from cells show potential for therapeutic agent development. EVs have… read more here.

Keywords: vesicles preclinical; non clinical; preclinical testing; characteristics extracellular ... See more keywords